Research Progress of SARS-CoV-2 Infection Mechanisms and COVID-19 Therapeutic Medicines

WANG Kang-hong

Life Science Research ›› 2020, Vol. 24 ›› Issue (6) : 442-451.

PDF(453 KB)
PDF(453 KB)
Life Science Research ›› 2020, Vol. 24 ›› Issue (6) : 442-451.

Research Progress of SARS-CoV-2 Infection Mechanisms and COVID-19 Therapeutic Medicines

Author information +
History +

Abstract

Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been prevalent among more than 200 countries around the world. It has a long incubation period, strong infectivity, and various modes of transmission. People are generally susceptible to it. At present, there are no specific drugs and vaccines that can treat or prevent the coronavirus disease 2019 (COVID-19) caused by the virus. However, notable progress has been achieved in theoretical researches and clinical analysis of SARS-CoV-2 and COVID-19. This arti-cle summarized the viral genome and origin analysis, the relationship between the receptor angiotensin con-verting enzyme 2 (ACE2) and the viral infection and pathogenesis, as well as current COVID-19 therapeutic drugs, in hope of providing a reference for awareness of future epidemic risks and searching for potential an-tiviral drugs.

Cite this article

Download Citations
WANG Kang-hong. Research Progress of SARS-CoV-2 Infection Mechanisms and COVID-19 Therapeutic Medicines[J]. Life Science Research, 2020, 24(6): 442-451
PDF(453 KB)

Accesses

Citation

Detail

Sections
Recommended

/